Susquehanna International Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-102,600
| Closed | -$1.85M | – | 11529 |
|
|
2020
Q2 | $1.85M | Buy |
102,600
+55,100
| +116% | +$766K | ﹤0.01% | 4649 |
|
|
2020
Q1 | $339K | Buy |
+47,500
| New | +$593K | ﹤0.01% | 7742 |
|
|
2019
Q4 | – | Sell |
-73,900
| Closed | -$1.98M | – | 11111 |
|
|
2019
Q3 | $1.98M | Sell |
73,900
-50,400
| -41% | -$1.41M | ﹤0.01% | 4215 |
|
|
2019
Q2 | $3.37M | Buy |
124,300
+62,800
| +102% | +$1.97M | ﹤0.01% | 3274 |
|
|
2019
Q1 | $2.13M | Sell |
61,500
-328,300
| -84% | -$9.47M | ﹤0.01% | 3644 |
|
|
2018
Q4 | $7.61M | Buy |
389,800
+301,900
| +343% | +$6.21M | ﹤0.01% | 1850 |
|
|
2018
Q3 | $2.34M | Buy |
87,900
+37,800
| +75% | +$1.23M | ﹤0.01% | 3748 |
|
|
2018
Q2 | $1.89M | Sell |
50,100
-31,600
| -39% | -$1.21M | ﹤0.01% | 4103 |
|
|
2018
Q1 | $2.67M | Sell |
81,700
-6,800
| -8% | -$298K | ﹤0.01% | 3438 |
|
|
2017
Q4 | $4.31M | Sell |
88,500
-117,800
| -57% | -$5.96M | ﹤0.01% | 2710 |
|
|
2017
Q3 | $11.1M | Sell |
206,300
-228,000
| -52% | -$13.4M | ﹤0.01% | 1675 |
|
|
2017
Q2 | $24.4M | Buy |
434,300
+183,800
| +73% | +$7.36M | 0.01% | 1013 |
|
|
2017
Q1 | $9.82M | Buy |
250,500
+117,700
| +89% | +$3.75M | 0.01% | 1650 |
|
|
2016
Q4 | $2.98M | Buy |
132,800
+25,600
| +24% | +$500K | ﹤0.01% | 3252 |
|
|
2016
Q3 | $2.44M | Sell |
107,200
-43,500
| -29% | -$1.02M | ﹤0.01% | 3238 |
|
|
2016
Q2 | $3.56M | Buy |
150,700
+80,700
| +115% | +$1.99M | ﹤0.01% | 2677 |
|
|
2016
Q1 | $1.43M | Sell |
70,000
-43,700
| -38% | -$1.39M | ﹤0.01% | 4400 |
|
|
2015
Q4 | $5.85M | Buy |
113,700
+84,300
| +287% | +$4.09M | ﹤0.01% | 2325 |
|
|
2015
Q3 | $1.25M | Buy |
29,400
+8,800
| +43% | +$425K | ﹤0.01% | 5220 |
|
|
2015
Q2 | $938K | Sell |
20,600
-9,300
| -31% | -$374K | ﹤0.01% | 6356 |
|
|
2015
Q1 | $1.14M | Buy |
29,900
+4,600
| +18% | +$158K | ﹤0.01% | 5492 |
|
|
2014
Q4 | $716K | Buy |
25,300
+5,600
| +28% | +$156K | ﹤0.01% | 6520 |
|
|
2014
Q3 | $498K | Buy |
19,700
+100
| +0.5% | +$2.63K | ﹤0.01% | 7218 |
|
|
2014
Q2 | $572K | Buy |
+19,600
| New | +$474K | ﹤0.01% | 7214 |
|
Susquehanna International Group's PTLA Position: Q3 2020 in Review
Susquehanna International Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 425,898 shares — an estimated $7.66M sold.
Susquehanna International Group first reported a position in PTLA in Q2 2013 and held it in 25 quarters. The position peaked at $23.9M in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Susquehanna International Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Susquehanna International Group sold 425,898 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $7.66M.
- Susquehanna International Group first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 25 quarters.
- Susquehanna International Group's Portola Pharmaceuticals, Inc. position peaked at $23.9M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.